| 000 | 01645 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513193444.0 | ||
| 264 | 0 | _c19991123 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a0004-4172 | ||
| 024 | 7 |
_a10.1055/s-0031-1300495 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNolte, K | |
| 245 | 0 | 0 |
_aIn vitro absorption studies with carvedilol using a new model with porcine intestine called BM-RIMO (Boehringer-Mannheim ring model). _h[electronic resource] |
| 260 |
_bArzneimittel-Forschung _cSep 1999 |
||
| 300 |
_a745-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xpharmacokinetics |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBile _xmetabolism |
| 650 | 0 | 4 | _aBuffers |
| 650 | 0 | 4 |
_aCarbazoles _xpharmacokinetics |
| 650 | 0 | 4 | _aCarvedilol |
| 650 | 0 | 4 |
_aChitin _xanalogs & derivatives |
| 650 | 0 | 4 | _aChitosan |
| 650 | 0 | 4 |
_aColon _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aIleum _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIntestinal Absorption _xdrug effects |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xdrug effects |
| 650 | 0 | 4 |
_aJejunum _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPropanolamines _xpharmacokinetics |
| 650 | 0 | 4 | _aSwine |
| 700 | 1 | _aBackfisch, G | |
| 700 | 1 | _aNeidlein, R | |
| 773 | 0 |
_tArzneimittel-Forschung _gvol. 49 _gno. 9 _gp. 745-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0031-1300495 _zAvailable from publisher's website |
| 999 |
_c10471956 _d10471956 |
||